Janux Therapeutics, Inc. · NASDAQ:JANX
Doyle Janeen Noel sold 4,059 Janux Therapeutics, Inc. shares (Form 4)
Traded Jun 2, 2026 · Filed Jun 4, 2026
On Jun 2, 2026, Doyle Janeen Noel (Chief Corp. & Bus. Dev. Ofcr) sold 4,059 Janux Therapeutics, Inc. shares at US$14.03 for US$56,948, leaving 75,941 shares. Filed Jun 4, 2026 (Form 4).
- Sold
- 4,059 shares
- Price
- US$14.03
- Value
- US$56,948
- Holding after
- 75,941 shares
- Trading plan
- No
- Role
- Chief Corp. & Bus. Dev. Ofcr
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 2, 2026 | Common Stock | Sale | 4,059 | US$14.03 | 75,941 | Direct |
Source
Related
- Janux Therapeutics, Inc.
- Doyle Janeen Noel
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026